may 16, 2018 - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.
Added to timeline:
Date:
may 16, 2018
Now
~ 7 years and 5 months ago